Injectable Antibiotic Therapies for Equine Systemic Infections: Top 7 UK Options for 2026

Excenel RTU EZ is a ready-to-use ceftiofur hydrochloride formulation favored for rapid treatment of respiratory and soft-tissue infections; its RTU format reduces preparation time and dosing errors, which can lower labor costs compared with multi-step products. For the use case "undefined", it stands out against other ceftiofur options like Naxcel by offering convenience and consistent dosing, though it can carry a premium price compared with some generic injectables.

Gentamicin sulphate 100 mg/ml is a widely used aminoglycoside valued for its low cost and potent activity against gram-negative pathogens, making it a common first-line injectable in budget-conscious settings. For the use case "undefined", it is a financially attractive alternative to higher-priced agents such as amikacin or proprietary cephalosporins, though it is more prone to resistance and nephrotoxicity than amikacin and lacks the broad tissue penetration of fluoroquinolones like enrofloxacin.

Naxcel is an established ceftiofur sodium product with a proven track record in food-animal practice, offering reliable third-generation cephalosporin coverage for respiratory and systemic infections. For the use case "undefined", Naxcel competes with Excenel RTU EZ on antimicrobial spectrum but often provides a cost-effective, widely available option for producers who prioritize drug familiarity and established withdrawal data over the convenience of RTU formulations.

Amikacin 250 mg/ml is a high-concentration aminoglycoside often reserved for severe or resistant gram-negative infections because it resists many aminoglycoside-modifying enzymes that inactivate gentamicin. For the use case "undefined", its technical advantage is clear against gentamicin-resistant isolates and some multi-drug infections, though that efficacy comes at higher drug cost and with similar nephrotoxicity risks, making it a specialty rather than routine choice.

Baytril (enrofloxacin) is a potent fluoroquinolone with excellent tissue penetration and broad-spectrum activity, particularly useful for difficult-to-reach or intracellular infections. For the use case "undefined", it offers technical superiority for deep-seated infections compared with many beta-lactams and aminoglycosides, but higher cost and regulatory restrictions in some species mean it is best used selectively and often as a second-line or culture-guided therapy.

Penbritin (ampicillin) is a classic, low-cost broad-spectrum penicillin suitable for many gram-positive and some gram-negative infections, making it a practical choice for routine, uncomplicated cases. For the use case "undefined", it provides strong financial value compared with cephalosporins like Excenel or Naxcel, although it is less effective against beta-lactamase–producing organisms and may be outperformed technically by potentiated sulfonamides or fluoroquinolones for certain infections.

Trimediazine is a potentiated sulfonamide combining trimethoprim and sulfadiazine to deliver broad-spectrum, synergistic bactericidal activity that is both effective and cost-efficient for many mixed infections. For the use case "undefined", it compares favorably to single-agent beta-lactams by offering enhanced coverage and often lower cost than some branded cephalosporins and fluoroquinolones, though resistance patterns and species-specific contraindications must guide its use.